Navigation Links
GenomeLab GeXP Genetic Analysis System from Beckman Coulter

ProductsGenomeLab GeXP Genetic Analysis System from Beckman Coulter
Company Beckman Coulter
Item GenomeLab GeXP Genetic Analysis System
Description The GenomeLab GeXP Genetic Analysis System provides high-throughput, quantitative gene expression analysis via scalable, multiplexed PCR*. The systems patented priming strategy overcomes the biases that limit standard multiplexed PCR analysis to just a few genes at a time. GenomeLab GeXP delivers more genes per reaction and more samples per run, removing bottlenecks in gene expression studies for drug discovery and development research. The system can run two 96-well plates in 24 hours, and cost effectively look at the expression of 20 to 30 genes in a single reaction per well. Ideal for applications working with smaller gene sets that can provide key information relating to biological state or response, GenomeLab GeXP operates at a fraction of the cost of a standard RT-PCR system. The system delivers highly accurate and quantitative results for hundreds or even thousands of samples using very small amounts of total RNA.

GenomeLab is a family of genetic analysis tools from Beckman Coulter that innovate, simplify and automate genomics processes to enable identification of new markers of biological, diagnostic and therapeutic interest.

Info Beckman CoulterBeckman Coulter
4300 N. Harbor Boulevard
PO Box 3100
Fullerton, CA 92834-3100
Customer Service: (800) 742-2345
Fax Number: (800) 643-4366
Web Site:
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GenomeLab SNPstream Genotyping System from Beckman Coulter
2. CEQ 8800 Genetic Analysis System from Beckman Coulter
3. CEQ 8000 Genetic Analysis System from Beckman Coulter
4. CEQ 8000 Genetic Analysis System from Beckman Coulter
5. CEQ 8000 Genetic Analysis System from Beckman Coulter
6. Human Genetic Cell Bank Service from European Collection of Cell Cultures (ECACC)
7. Mutation Surveyor from SoftGenetics, LLC.
8. GeneMarker from SoftGenetics, LLC.
9. Genetic Mapping of Disease Genes from Promega
10. GIBCO Geneticin Selective Antibiotic liquid from Invitrogen
11. Mutation Explorer from SoftGenetics, LLC.
Human peripheral blood neutrophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Human endothelial progenitor cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Umbilical cord blood neutrophils, For immunohistochemistry (IHC)...
Biology Products:
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... Diego, CA (PRWEB) , ... June 27, 2016 , ... ... solutions for clinical trials, announced today the Clinical Reach Virtual Patient Encounter ... their care circle with the physician and clinical trial team. , Using the CONSULT ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
Breaking Biology Technology: